_id

690f3ab8ccc777a4e85d196e

Ticker

CADL

Name

Candel Therapeutics Inc

Exchange

NASDAQ

Address

117 Kendrick Street, Needham, MA, United States, 02494

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.candeltx.com

Description

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients. It develops CAN-2409, which is in Phase III clinical trials for the treatment of prostate cancer; Phase II clinical trials for the treatment of pancreatic cancer; and Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). The company is also developing CAN-3110, which is in Phase Ib clinical trials for the treatment of recurrent high-grade glioma. In addition, it develops the enLIGHTEN Discovery Platform, a systematic, iterative herpes simplex virus based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapy candidates for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.

Last Close

6.47

Volume

478068

Current Price

6.35

Change

-1.8547140649149938

Last Updated

2025-11-29T11:06:30.338Z

Image

data:image/webp;base64,UklGRiACAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSFcBAAANgDTbetrmk5SY7XHMnUlS7rJd9f/vmZbMNZdth1QmfftOREwAfMr8ldWVpciSKAjIh4/Jwf7aTjqCbyrshU84fwFBCaWUkUnzlRTMRMOyKKrxixCESbrjOXJynjSfkDCasmsOwhImaZ3A0+/jm5gDgBxOe+UjiE5Mp+eWFzcNQBD5CgeE+lx3WMRxS5mOSg44va4Xn/sstB8B61z3IVt+GdWAVnN1ZZWXHA8Ygbs8KQAxCbwljgpsJ3x5RqXp1ssYldSW4QUVpQz+e8mBEFxDYAzTC38gsoRpOEqopmOqqkPi2pjuy33mBgRRmq9TxzPxPGXFDpU0V8dSl491MkkfunNYTi8Me9Scx27Xw3F7kQcAkNwUo+6cJl5zetayVQBo4ovC6zkGEeulKi5ym8FHHt/ED4YfdDSJiPEyqu7S9NEMVfi8ic9TxfMcvU3F4KPqNs9qGz4CAFZQOCCiAAAAUAYAnQEqQABAAD61TqBMJyQjIiocyjDgFolnAABw63qe2VEKEQViTJUe2AnKJgzO0JKigGc0jN0QEVAA/vccJFSVzQNy1YZpdPHOD0CpAvxjVFd1vhc75l0bnjuHJSdtdRzSLMRkg8SXDvhKxlaqc7SFSy1Lt1DhlCcTRxZXrKP0Gjrvxz11icsV6WDziUP7qdWjcoM8Gty+oPskYexUAAAA

Ipo Date

2021-07-27T00:00:00.000Z

Market Cap

261864912

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.48224999999999996

Sentiment Sources

4

Rating

5

Target Price

18.625

Strong Buy

3

Buy

0

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

195000

Gross Profit

-195000

Operating Expenses

13012000

Operating Income

-13207000

Interest Expense

161000

Pretax Income

-11269000

Net Income

-11269000

Eps

-0.2052852546000775

Dividends Per Share

-

Shares Outstanding

54898303

Income Tax Expense

-

EBITDA

-10913000

Operating Margin

-

Total Other Income Expense Net

1938000

Cash

86963000

Short Term Investments

-

Receivables

-

Inventories

-

Total Current Assets

90134000

Property Plant Equipment

3113000

Total Assets

93598000

Payables

1118000

Short Term Debt

4662000

Long Term Debt

973000

Total Liabilities

13474000

Equity

80124000

Depreciation

195000

Change In Working Capital

356000

Cash From Operations

-10236000

Capital Expenditures

144000

Cash From Investing

-117000

Cash From Financing

-3371000

Net Change In Cash

-13724000

PE

-

PB

4.350495525061155

ROE

-14.064450102341372

ROA

-12.039787174939635

FCF

-10380000

Fcf Percent

-

Piotroski FScore

1

Health Score

38

Deep Value Investing Score

4

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

5

Net Net Investing Score

1.5

Quality Investing Score

2.5

Value Investing Score

3.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

195000

Quarters > 0 > income Statement > gross Profit

-195000

Quarters > 0 > income Statement > operating Expenses

13012000

Quarters > 0 > income Statement > operating Income

-13207000

Quarters > 0 > income Statement > interest Expense

161000

Quarters > 0 > income Statement > pretax Income

-11269000

Quarters > 0 > income Statement > net Income

-11269000

Quarters > 0 > income Statement > eps

-0.2052852546000775

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

54894347

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-10913000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

1938000

Quarters > 0 > balance Sheet > cash

86963000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

90134000

Quarters > 0 > balance Sheet > property Plant Equipment

3113000

Quarters > 0 > balance Sheet > total Assets

93598000

Quarters > 0 > balance Sheet > payables

1118000

Quarters > 0 > balance Sheet > short Term Debt

4662000

Quarters > 0 > balance Sheet > long Term Debt

973000

Quarters > 0 > balance Sheet > total Liabilities

13474000

Quarters > 0 > balance Sheet > equity

80124000

Quarters > 0 > cash Flow > net Income

-11269000

Quarters > 0 > cash Flow > depreciation

195000

Quarters > 0 > cash Flow > change In Working Capital

356000

Quarters > 0 > cash Flow > cash From Operations

-10236000

Quarters > 0 > cash Flow > capital Expenditures

144000

Quarters > 0 > cash Flow > cash From Investing

-117000

Quarters > 0 > cash Flow > cash From Financing

-3371000

Quarters > 0 > cash Flow > net Change In Cash

-13724000

Quarters > 0 > ratios > PE

-0.2052852546000775

Quarters > 0 > ratios > PB

4.350495525061155

Quarters > 0 > ratios > ROE

-14.064450102341372

Quarters > 0 > ratios > ROA

-12.039787174939635

Quarters > 0 > ratios > FCF

-10380000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

38

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

242000

Quarters > 1 > income Statement > gross Profit

-242000

Quarters > 1 > income Statement > operating Expenses

10935000

Quarters > 1 > income Statement > operating Income

-11177000

Quarters > 1 > income Statement > interest Expense

236000

Quarters > 1 > income Statement > pretax Income

-4796000

Quarters > 1 > income Statement > net Income

-4796000

Quarters > 1 > income Statement > eps

-0.0931444283016976

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

51489929

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-4318000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

6381000

Quarters > 1 > balance Sheet > cash

100687000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

103608000

Quarters > 1 > balance Sheet > property Plant Equipment

2049000

Quarters > 1 > balance Sheet > total Assets

105968000

Quarters > 1 > balance Sheet > payables

1953000

Quarters > 1 > balance Sheet > short Term Debt

7298000

Quarters > 1 > balance Sheet > long Term Debt

939000

Quarters > 1 > balance Sheet > total Liabilities

15758000

Quarters > 1 > balance Sheet > equity

90210000

Quarters > 1 > cash Flow > net Income

-4796000

Quarters > 1 > cash Flow > depreciation

242000

Quarters > 1 > cash Flow > change In Working Capital

67000

Quarters > 1 > cash Flow > cash From Operations

-8891000

Quarters > 1 > cash Flow > capital Expenditures

31000

Quarters > 1 > cash Flow > cash From Investing

-31000

Quarters > 1 > cash Flow > cash From Financing

17444000

Quarters > 1 > cash Flow > net Change In Cash

8522000

Quarters > 1 > ratios > PE

-0.0931444283016976

Quarters > 1 > ratios > PB

3.624443511251524

Quarters > 1 > ratios > ROE

-5.316483760115286

Quarters > 1 > ratios > ROA

-4.525894609693493

Quarters > 1 > ratios > FCF

-8922000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

37

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

245000

Quarters > 2 > income Statement > gross Profit

-245000

Quarters > 2 > income Statement > operating Expenses

7885000

Quarters > 2 > income Statement > operating Income

-8130000

Quarters > 2 > income Statement > interest Expense

306000

Quarters > 2 > income Statement > pretax Income

7379000

Quarters > 2 > income Statement > net Income

7379000

Quarters > 2 > income Statement > eps

0.2329591884799266

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

31675076

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

7930000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

15509000

Quarters > 2 > balance Sheet > cash

92165000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

93148000

Quarters > 2 > balance Sheet > property Plant Equipment

2433000

Quarters > 2 > balance Sheet > total Assets

95905000

Quarters > 2 > balance Sheet > payables

760000

Quarters > 2 > balance Sheet > short Term Debt

9752000

Quarters > 2 > balance Sheet > long Term Debt

904000

Quarters > 2 > balance Sheet > total Liabilities

21230000

Quarters > 2 > balance Sheet > equity

74675000

Quarters > 2 > cash Flow > net Income

7379000

Quarters > 2 > cash Flow > depreciation

245000

Quarters > 2 > cash Flow > change In Working Capital

-1825000

Quarters > 2 > cash Flow > cash From Operations

-8616000

Quarters > 2 > cash Flow > capital Expenditures

3000

Quarters > 2 > cash Flow > cash From Investing

-3000

Quarters > 2 > cash Flow > cash From Financing

-1870000

Quarters > 2 > cash Flow > net Change In Cash

-10489000

Quarters > 2 > ratios > PE

0.2329591884799266

Quarters > 2 > ratios > PB

2.693494912621359

Quarters > 2 > ratios > ROE

9.881486441245396

Quarters > 2 > ratios > ROA

7.694072259006308

Quarters > 2 > ratios > FCF

-8619000

Quarters > 2 > ratios > Piotroski FScore

2

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

72

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

1000000

Quarters > 3 > income Statement > cost Of Revenue

245000

Quarters > 3 > income Statement > gross Profit

-245000

Quarters > 3 > income Statement > operating Expenses

7896000

Quarters > 3 > income Statement > operating Income

-8141000

Quarters > 3 > income Statement > interest Expense

390000

Quarters > 3 > income Statement > pretax Income

-14073000

Quarters > 3 > income Statement > net Income

-14073000

Quarters > 3 > income Statement > eps

-0.3957032692799972

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

35564528

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-13438000

Quarters > 3 > income Statement > operating Margin

-814.1

Quarters > 3 > income Statement > total Other Income Expense Net

-5932000

Quarters > 3 > balance Sheet > cash

102654000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

103804000

Quarters > 3 > balance Sheet > property Plant Equipment

2733000

Quarters > 3 > balance Sheet > total Assets

106866000

Quarters > 3 > balance Sheet > payables

237000

Quarters > 3 > balance Sheet > short Term Debt

10461000

Quarters > 3 > balance Sheet > long Term Debt

2603000

Quarters > 3 > balance Sheet > total Liabilities

40539000

Quarters > 3 > balance Sheet > equity

66327000

Quarters > 3 > cash Flow > net Income

-14073000

Quarters > 3 > cash Flow > depreciation

245000

Quarters > 3 > cash Flow > change In Working Capital

743000

Quarters > 3 > cash Flow > cash From Operations

-5814000

Quarters > 3 > cash Flow > capital Expenditures

3000

Quarters > 3 > cash Flow > cash From Investing

-3000

Quarters > 3 > cash Flow > cash From Financing

91913000

Quarters > 3 > cash Flow > net Change In Cash

86096000

Quarters > 3 > ratios > PE

-0.3957032692799972

Quarters > 3 > ratios > PB

3.40486910006483

Quarters > 3 > ratios > ROE

-21.217603690804648

Quarters > 3 > ratios > ROA

-13.168828252203694

Quarters > 3 > ratios > FCF

-5817000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-5.817

Quarters > 3 > health Score

26

Valuation > metrics > PE

-0.2052852546000775

Valuation > metrics > PB

4.350495525061155

Valuation > final Score

36.49504474938845

Valuation > verdict

45.0% Overvalued

Profitability > metrics > ROE

-14.064450102341372

Profitability > metrics > ROA

-12.502496283311515

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.1681643452648395

Risk > metrics > Interest Coverage

-82.03105590062111

Risk > final Score

-268

Risk > verdict

High

Liquidity > metrics > Current Ratio

15.594117647058823

Liquidity > metrics > Quick Ratio

15.594117647058823

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

43.75556488748476

Prev Valuations > 1

100

Prev Valuations > 2

45.9513089993517

Prev Profitabilities > 0

15

Prev Profitabilities > 1

59

Prev Profitabilities > 2

0

Prev Risks > 0

-129

Prev Risks > 1

-46

Prev Risks > 2

-35

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:18:42.043Z